A phase I, open-label, dose-escalation study investigating a low-density lipoprotein receptor-related protein (LRP) 5/6 inhibitor, BI 905677, in patients with advanced solid tumors Meeting Abstract
| Authors: | Élez, E.; Lenz, H. J.; de Jonge, M.; Yaeger, R.; Doi, T.; Pronk, L.; Teufel, M.; Marzin, K.; Tabernero, J. |
| Abstract Title: | A phase I, open-label, dose-escalation study investigating a low-density lipoprotein receptor-related protein (LRP) 5/6 inhibitor, BI 905677, in patients with advanced solid tumors |
| Meeting Title: | 113th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 82 |
| Issue: | 12 Suppl. |
| Meeting Dates: | 2022 Apr 8-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2022-06-15 |
| Language: | English |
| ACCESSION: | WOS:000892509500033 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.AM2022-CT514 |
| Notes: | Meeting Abstract: CT514 -- Source: Wos |
